Astra Zeneca 70% effectiveness a worry?
At the end of January, the EU Medicines Agency could approve the Coronavirus vaccine from Oxford University and Astra Zeneca. The protection rate – according to interim evaluations of the data – is 70%.
So, 70 out of 100 people are protected from Coronavirus after infection. At Biontech / Pfizer and Moderna, it is more than 90%.
At 70%, the protection rate of Astra Zeneca is lower than that of the competition. However, if a weaker first partial vaccination is given, 90% is achieved.
A protection rate of 70% is still higher than that of the influenza vaccine (up to a maximum of 60%). In the case of influenza, for example, those who fall ill, despite being vaccinated, usually have a milder course, with fewer complications.
At the end of January, the Covid-19 vaccine from Oxford University could be approved in the EU, in cooperation with the pharmaceutical company Astra Zeneca. The phase II / III study was published as an interim evaluation.
The preparation from Oxford University and Astra Zeneca, should prevent slightly fewer diseases, than the RNA vaccines from Biontech and Moderna.
At a maximum of 70%, the protection rate of Astra Zeneca could be significantly lower than that of the mRNA vaccines of Biontech / Pfizer, Moderna – each more than 90 percent effective.
Chirag Vasani is Chief Editor for Globanomy. He has been writing online and offline since many years now. When he is not writing, he likes to play golf.
